CAS RN: 116228-41-2
4-broMo-1-tosyl-1H-pyrazole
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 116228-41-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shanghai
Inquiry
116228-41-2 / 4-bromo-1-(4-methylphenyl)sulfonylpyrazole
4-bromo-1-tosyl-1H-pyrazole | MFCD06080375 | 4-bromo-1-(4-methylphenyl)sulfonylpyrazole
Standard CAS: 116228-41-2
Multi CAS: No
Basic Information
copy
CAS
116228-41-2 copy
Multi CAS
No copy
Molecular Formula
C10H9BrN2O2S copy
Molecular Weight
301.160000 copy
Exact Mass
299.956810 copy
SMILES
CC1=CC=C(C=C1)S(=O)(=O)N2C=C(C=N2)Br copy
InChI
InChI=1S/C10H9BrN2O2S/c1-8-2-4-10(5-3-8)16(14,15)13-7-9(11)6-12-13/h2-7H,1H3 copy
InChIKey
XRKOINRPMVFMFN-UHFFFAOYSA-N copy
Synonyms
4-bromo-1-tosyl-1H-pyrazole
MFCD06080375
4-bromo-1-(4-methylphenyl)sulfonylpyrazole
1H-Pyrazole, 4-bromo-1-[(4-methylphenyl)sulfonyl]-
4-Bromo-1-[(4-methylbenzene)sulfonyl]pyrazole copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Aromatic heavy atom count
11 copy
Fraction Csp3
0.1 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
Molar refractivity
63.69 copy
TPSA
51.96 copy
LogP / Solubility
WLOGP
2.19 copy
MLOGP
1.94 copy
XLogP3
2.5 copy
Consensus LogP
2.21 copy
Log S (ESOL)
-3.46 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.61 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.68 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy